Followers | 17 |
Posts | 1413 |
Boards Moderated | 0 |
Alias Born | 12/19/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 23, 2021 9:47:53 AM
Recent MNPR News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:07:29 PM
- Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule • GlobeNewswire Inc. • 08/27/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 12:00:13 PM
- Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers • GlobeNewswire Inc. • 08/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:00:10 PM
- Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 12:02:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 12:01:37 PM
- Monopar Therapeutics Announces 1-for-5 Reverse Stock Split • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 07/22/2024 11:01:16 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/22/2024 11:00:07 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/11/2024 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:01:43 PM
- Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr • GlobeNewswire Inc. • 07/09/2024 11:00:00 AM
- Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24 • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:08:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 11:30:32 AM
- Monopar and NorthStar Amend & Extend Collaboration • GlobeNewswire Inc. • 06/11/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 12:00:17 PM
- Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting • GlobeNewswire Inc. • 06/10/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 10:12:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:56:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 10:10:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:59:02 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM